Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

Condition:   Ulcerative Colitis Interventions:   Drug: CU104;   Drug: Placebo Sponsor:   Curacle Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials